• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Plasma Therapy Companies

    ID: MRFR/Pharma/9249-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    Plasma therapy, also known as convalescent plasma therapy, involves using the plasma from individuals who have recovered from a specific infection to treat others. This therapeutic approach has been explored for various infectious diseases, including viral infections.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Plasma Therapy Market

    Plasma Therapy Key Companies

     


    Latest Plasma Therapy Companies Update:

    Octapharma


    January 22, 2024: Published data from the WIL-31 study, marking a milestone in improving long-term care for severe von Willebrand disease (VWD) patients.January 9, 2024: Announced availability of Balfaxar® for warfarin reversal in urgent surgery and invasive procedures.


    CSL (Australia)


    April 2023: Received FDA approval for a new prefilled syringe of Hizentra for patients with primary immunodeficiency (PI) and chronic inflammatory demyelinating polyneuropathy (CIPD).


    Grifols (Spain)


    March 2022 Received European approvals for XEMBIFY, a 20% subcutaneous immunoglobulin (SCIG) for PI treatment.


    List of Plasma Therapy Key companies in the market

    • BioLife Plasma Services (US)

    • Cambryn Biologics LLC (US)

    • Biotest (Germany)

    • CSL Ltd. (Australia)

    • Grifols International S.A. (Spain)

    • Kedrion S.p.A. (Italy)

    • LFB S.A (France)

    • Bio Products Laboratory Ltd. (U.K.)

    • China Biologic Products, Inc. (China)

    • Octapharma (Switzerland)

    • Arthrex, Inc. (US)

    • DePuy Synthes Companies (US)

    • Grifols S.A (Spain)

    • Global Stem Cells Group, Inc. (US)

    • Juventix Regenerative Medical LLC (U.S.)

    • Celling Biosciences, Inc. (U.S.)